Allergen vial mixing and immunotherapy: Risks of infections and vial contamination

Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 2, 2007, Pages 243-245

  Lay, P Chase ^a   Bass, Richard ^a   Lin, Sandra Y ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ANAPHYLAXIS; ARTICLE; BACTERIUM CONTAMINATION; CELLULITIS; CONTROLLED STUDY; DOSE RESPONSE; DYSPNEA; FEVER; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; OUTPATIENT CARE; RETROSPECTIVE STUDY; RISK FACTOR; SKIN INFECTION; SKIN MANIFESTATION; TERTIARY HEALTH CARE; WHEEZING;

ALLERGENS; BALTIMORE; DRUG CONTAMINATION; FEMALE; HUMANS; IMMUNOTHERAPY; INFECTION; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 34547122890     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2007.02.012     Document Type: Article

References (14)

1. Lockey R. Adverse reactions associated with skin testing and immunotherapy. Allergy Proc 16 6 (1995) 292-296
2. US Pharmacopeial Convention, Inc. Chapter <797> Pharmaceutical compounding-sterile peparations (2004), US Pharmacopeial Convention, Rockville (MD) 2461-2477 US Pharmacopeia 28
3. Joint commissions perspectives on patient safety. Jt Comm Perspect 6 4 (2006) 5
4. King H.C., Mabry R.L., and Mabry C.S. Allergy in ENT practice: a basic guide (1998), Thieme, New York 200-249
5. King H.C., Mabry R.L., and Mabry C.S. Allergy in ENT practice: a basic guide (1998), Thieme, New York 291-294 306
6. Iglesias-Cadarso A., Hernandez-Weigand P., Reano M., et al. A prospective safety study of allergen immunotherapy in daily clinical practice. Allergol Immunopathol 32 5 (2004) 278-283
7. Norman P.S., and Van Metre T.E. The safety of allergenic immunotherapy. J Allergy Clinic Immunol 85 2 (1999) 522-525
8. Ragusa V.F., and Massolo A. Non-fatal systemic reactions to subcutaneous immunotherapy: a 20-year experience comparison of two 10-year periods. Eur Ann Allergy Clin Immunol 36 2 (2004) 52-55
9. Lin M.S., Tanner E., Lynn J., et al. Nonfatal systemic allergic reactions induced by skin testing and immunotherapy. Ann Allergy 71 (1993) 557-562
10. Nelson H.S., Ikle D., and Buchmeier A. Studies of allergen extract stability: the effects of dilution and mixing. J Allergy Clin Immunol 98 (1996) 382-388
11. Nelson H.S. Effect of preservatives and conditions of storage on the potency of allergy extracts. J Allergy Clin Immunol 67 1 (1981) 64-69
12. Menardo J.L., Bousquet J., Bataille A., et al. Effects of diluents on skin tests. Ann Allergy 51 (1983) 535-538
13. Can D., Demir E., Tanac R., et al. Immediate adverse reactions to immunotherapy. J Inmestic Allerg Clin Immunol 13 3 (2003) 177-180
14. Arifhadzic N., Behbehani N., Duwaisin A.R., et al. Safety of subcutaneous specific immunotherapy with pollen allergen extracts for respiratory allergy. Int Arch Allergy Immunol 132 (2003) 258-262